Info
01480 839 015

  • awesomeicons6/solid/lock 100% Secure Online Payments

Alacizumab (Anti-VEGFR2 / KDR / CD309)

Selleck

Alacizumab (Anti-VEGFR2 / KDR / CD309) (A3109-GRP)

View Data Sheet
Contact us about this product

Products

Sort by arrow-down-short-wide arrow-up-short-wide
Cat #
Size
Price
Cat # Size
chevron-left chevron-right
of

Description

Alacizumab (Anti-VEGFR2 / KDR / CD309) is a humanized monoclonal antibody targeting VEGFR2 / KDR / CD309 . It has anti-tumour effect in tumour growth. MW :144.08 KD.

Specifications

Manufacturer Cat# A3109